PROFESSIONAL STAFF ELECTIONS
During the month of February, we will solicit nominations for the three
major professional staff leadership positions. These are: the chair of
medicine, the chair of surgery and the chair-elect of the professional
staff. Of note, the chair-elect will come from the pool of active surgery
department professional staff members. If you are an active member of the
professional staff and would like to nominate a colleague for one of these
positions, please submit the nomination in writing to Jeff Adam, MD,
Robert Myers, DO, or Tom Murphy, MD. Please identify yourself as the
nominator (to allow confirmation that you are an active member of the
professional staff). Failure to provide your name as the nominator will
invalidate the nomination. The deadline for receipt of the nomination is
February 29, 2008.
HEPARIN AND NORMAL SALINE PRE-FILLED FLUSHES ARE RECALLED
AM2 PAT, Inc., notified health care professionals and patients of a
nationwide recall of all lots of both Heparin and Normal Saline pre-filled
flushes. These products are distributed under two brand names, Sierra
Pre-Filled Inc., and B. Braun. The products are sold in 3ml and 5ml sizes
for Heparin and 3ml, 5ml and 10ml sizes for Normal Saline. One lot of
Heparin IV flush syringes (1003-02, Lot 070926H) was contaminated with
Serratia marcescens, which has resulted in patient infections. This type
of bacterial infection could present a serious adverse health consequence
that could lead to life-threatening injuries and/or death.
User facilities and consumers should stop using the product immediately,
quarantine remaining inventory and return the product to their respective
distributor. For a complete list of the recalled products, see the Recall
Notice.
COUGH AND COLD MEDICATIONS IN CHILDREN LESS THAN 2 YEARS OF AGE
The Federal Drug Administration (FDA) informed consumers and health care
professionals that the agency has completed its review of information
regarding the safety of over-the-counter (OTC) cough and cold medicines in
children under 2 years of age and recommends that these drugs not be used
to treat children in this age group because serious and potentially
life-threatening side effects can occur. The FDA’s recommendation is
based on both the review of the information the agency received about
serious side effects in children in the referenced age group and the
discussion and recommendations made at the October 18-19, 2007, public
advisory committee meeting at which this issue was discussed. The FDA has
not completed its review of information about the safety of OTC cough and
cold medicines in children 2 through 11 years of age. See the FDA Public
Health Advisory for Agency recommendations regarding this issue.
EVENTS ON THE HORIZON
February 2008—Nominations for professional staff leaders
Professional Staff Banquet—March 7, 2008. Look for invitations soon.
CME online
Sign up for Pediatric Link
Finding the latest trusted child health and safety information doesn't have to be hard. Pediatric Link, Dayton Children's e-newsletter offers timely and up-to-date information for health care professionals from the experts you trust at Dayton Children's. Sign up
Dayton Children's
+ How did we do?
Copyright © 2010The Children's Medical Center of Dayton
One Children's Plaza
Dayton, Ohio 45404-1815
937-641-3000